Skip to main content

Table 3 Proportion of patients achieving K/DOQI targets

From: Barriers to successful care for chronic kidney disease

  Stage 4 CKD Stage 5 CKD
  SNC (N = 23) LNC (N = 70) p-value SNC (N = 29) LNC (N = 76) p-value
Calcium 87% 91% 0.529 79% 82% 0.791
Phosphate 48% 80% 0.003 52% 66% 0.185
Calcium-Phosphate Product 65% 94% <0.001 83% 78% 0.789
iPTH 9% 20% 0.213 24% 21% 0.733
Bicarbonate 70% 81% 0.230 38% 49% 0.323
Albumin 43% 76% 0.004 48% 62% 0.208
Hemoglobin 57% 77% 0.056 38% 42% 0.697
Lipids 35% 49% 0.249 34% 49% 0.191
Triglycerides 91% 94% 0.614 90% 96% 0.207
LDL 39% 53% 0.253 48% 55% 0.521
Non-HDL 52% 63% 0.253 66% 76% 0.249
Blood Pressure 17% 34% 0.132 10% 17% 0.382
  1. Shown are the percentages of patients in each group with laboratory values within K/DOQI target ranges. Laboratory data were the most recent values within the 3 months period preceding the last clinic visit. See methods section for individual ranges. Stage 4 = GFR 15–29, Stage 5 = GFR <15 ml/min/1.73 m2. The glomerular filtration rate was estimated using the modified MDRD formula [1]. LNC: seen by a nephrologist for more than 6 months; SNC: seen by a nephrologist for 6 months or less. Data for LNC and SNC were compared using Chi Square Analysis. Only p-values < 0.05 are shown.